DrugDashboards

Ketamine Hydrochloride

Ketamine Hydrochloride · KETAMINE HYDROCHLORIDE 100 mg/mL · Injection, Solution, Concentrate · Intramuscular; Intravenous · Hospira, Inc.

NDC 00409-2051-05 · 10 VIAL, MULTI-DOSE in 1 BOX / 5 mL in 1 VIAL, MULTI-DOSE · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price has held steady around $1.54 per mL over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$1.54per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Federal contracts pay (FSS)$65.73per package of 10X5MLPfizer Inc. · Jul 1, 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00Nov 2025Sep 2026$1.54
10 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$83.13
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$23,171
1,182 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 3 active manufacturers+10
  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.4%chance of a new FDA shortage posting for ketamine hydrochloride (injectable) in the next 90 days

sterile injectable · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

  • Hospira, Inc.United States
    analysis · label · manufacture · pack

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA074549
TE code
AP
Approval date
Jun 27, 1996
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation Ketamine Hydrochloride, Injection, 500 mg/5mL (100 mg/mL); Multiple Dose Glass Fliptop Vial Novaplus (NDC 0409-0040-10)Nov 7, 2025

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ketamine Hydrochloride (Injection, Solution, Concentrate)

LabelerStrengthFirst seenLast seen
Henry Schein, Inc.KETAMINE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.KETAMINE HYDROCHLORIDE 100 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.KETAMINE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCKETAMINE HYDROCHLORIDE 100 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.KETAMINE HYDROCHLORIDE 100 mg/mLJul 15, 2026Jul 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ketamine Hydrochloride — NDC 00409-2051-05," retrieved September 3, 2026, https://drugdashboards.com/drug/00409205105.

Free to cite with attribution — see how the data is put together.